4868 RUE LEVY, SUITE 220, SAINT-LAURENT, A8
Market cap: $444.9M (12/18/2025)
Price: $8.69
Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants
Investor Presentation
Appoints Hussein Sweiti, M.D., MSc, as Chief Medical Officer
Reports Third Quarter 2025 Financial Results and Provides Business Update
Achieves Target Enrollment Milestone for LEGEND Trial Pivotal Cohort
Appoints Philip Astley-Sparke as Co-Founder and Executive Chairman
Reports Second Quarter 2025 Financial Results and Provides Business Update
Changes in Board, Management or Compensation, Shareholder votes
Q3
Q2
Q1
Amended Annual Report
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership